DEA Adds Separate Listing for Hexahydrocannabinol

The Drug Enforcement Administration has updated its drug scheduling regulations to give hexahydrocannabinol (HHC) its own specific entry in Schedule I. HHC is a synthetic compound related to THC and has already been treated as a Schedule I controlled substance under the Controlled Substances Act. This rule does not change its legal status or the penalties attached to it.

Why it matters: This is primarily an administrative update to align U.S. drug scheduling with a United Nations decision. The practical effect is limited to how the DEA tracks and issues permits for HHC. Manufacturers, researchers, and importers who need federal authorization to handle the compound will now use a new drug code instead of the general tetrahydrocannabinol code. The drug remains fully illegal for recreational use, and no new criminal penalties or compliance burdens are created by this rule.

Who it affects

• DEA-registered manufacturers and researchers who produce or handle HHC and need federal permits

---

This action was published by the Drug Enforcement Administration in the Federal Register; verify the full text and official drug code assignment before relying on it for regulatory or compliance purposes.

Agency: Justice Department, Drug Enforcement Administration
Source: Federal Register — read the official document